Recent Finacing
Recent Raise
Catamaran Bio develops off-the-shelf allogeneic CAR-NK cancer therapies, using its TAILWIND platform for design, non-viral genetic engineering, manufacturing, and potency-enhancing switches, advancing multiple lead CAR-NK programs.
